Review paper
The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension
Volume: 126, Issue: 1, Pages: 32 - 42
Published: Sep 13, 2019
Abstract
Pulmonary arterial hypertension (PAH) is a rare but life-threatening disease that progresses rapidly and is currently without a cure. Pharmacological treatments aim to slow down disease progression and to reduce symptoms by targeting the prostacyclin, the endothelin or the nitric oxide pathway. Drugs targeting the prostacyclin pathway have been shown to be favourable for PAH patients by causing vasodilatative, anti-proliferative as well as...
Paper Details
Title
The prostacyclin analogue treprostinil in the treatment of pulmonary arterial hypertension
Published Date
Sep 13, 2019
Volume
126
Issue
1
Pages
32 - 42
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History